Compass Therapeutics, Inc. (CMPX) - Quarterly Income Statement

Home
CMPX
Financials

1.7 (USD) • At close November 4, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	2.844	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.463	0.468	0.466	0.475	0.481	0.484	0.487	0.498	0.435	0.396	0.406	0.409	0.413	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.463	2.376	-0.466	-0.475	-0.481	-0.484	-0.487	-0.498	-0.435	-0.396	-0.406	-0.409	-0.413	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0.835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	9.368	12.265	8.831	10.223	6.638	9.928	9.791	5.862	4.415	9.574	3.154	2.905	4.704	4.406	3.67	2.985	3.571	3.303	5.979	5.389	7.243
General & Administrative Expenses Numbers are in millions	3.248	2.967	3.095	3.114	3.073	2.96	2.807	3.125	2.767	3.427	2.7	2.166	2.635	3.544	5.291	2.085	2.26	3.099	2.404	3.284	3.351
Selling & Marketing Expenses Numbers are in millions	-0.309	-0.307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	2.939	2.66	3.095	3.114	3.073	2.96	2.807	3.125	2.767	3.427	2.7	2.166	2.635	3.544	5.291	2.085	2.26	3.099	2.404	3.284	3.351
Other Expenses Numbers are in millions	1.983	-1.874	0	0	1.874	0	0	0	0	50.618	-0.044	50.618	0	-18.42	-8.952	0	-2.228	0	0	0	0
Operating Expenses Numbers are in millions	12.307	14.925	11.926	13.337	9.711	12.888	12.598	8.987	7.182	13.001	5.854	5.071	7.339	7.95	8.961	5.07	5.831	6.402	8.383	8.673	10.658
Operating Income Numbers are in millions	-12.77	-15.393	-11.926	-13.337	-9.711	-12.888	-12.598	-8.987	-7.182	-13.001	-5.854	-55.689	-7.339	-7.95	-8.961	-5.07	-5.831	-6.402	-8.383	-8.673	-10.594
Operating Income Ratio Numbers are in millions	0	-5.412	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	1.983	1.978	1.962	2.059	1.874	1.294	0.623	0.493	0.02	0.042	-0.044	-50.618	0.044	-0.281	0.001	-0.236	-0.32	-0.012	-0.007	-0.033	-0.148
Income Before Tax Numbers are in millions	-10.787	-13.415	-9.964	-11.278	-7.837	-11.594	-11.975	-8.494	-7.162	-12.994	-5.975	-55.791	-7.422	-8.391	-9.15	-5.541	-6.386	-6.602	-8.526	-8.783	-10.742
Income Before Tax Ratio Numbers are in millions	0	-4.717	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0.42	1.874	0.506	0.353	-1.874	-1.294	-0.623	-0.493	-0.02	-0.013	0.034	0.013	0.142	0.178	0.212	0.016	0.016	0.01	0.026	0.026	0.029
Net Income Numbers are in millions	-10.787	-13.415	-9.964	-11.278	-5.963	-10.3	-11.352	-8.001	-7.142	-12.981	-5.975	-55.804	-7.422	-8.391	-9.15	-5.557	-6.402	-6.612	-8.552	-8.809	-10.771
Net Income Ratio Numbers are in millions	0	-4.717	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.079	-0.11	-0.078	-0.089	-0.047	-0.098	-0.11	-0.079	-0.071	-0.25	-0.097	-1.07	-0.14	-0.14	-0.15	-0.11	-0.12	-0.11	-0.16	-0.17	-2.15
EPS Diluted Numbers are in millions	-0.079	-0.11	-0.078	-0.089	-0.047	-0.098	-0.11	-0.079	-0.071	-0.25	-0.097	-1.07	-0.14	-0.14	-0.15	-0.11	-0.12	-0.11	-0.16	-0.17	-2.15
EBITDA Numbers are in millions	-12.307	-14.925	-11.46	-12.862	-9.23	-11.11	-11.488	-8.065	-6.727	-12.601	-5.491	-4.653	-6.911	-6.863	-8.504	-4.626	-5.327	-5.785	-7.668	-8.436	-10.068
EBITDA Ratio Numbers are in millions	0	-5.248	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Compass Therapeutics, Inc.

NASDAQ:CMPX Add to watchlist

NASDAQ:CMPX